ACE inhibitors reduce inflammation and fibrosis by lowering IL-6 and TNF-α (76), and also trigger the apoptosis of cardiac fibroblasts, which generate pathological ECM components for myocardial fibrosis (3, 34). This evidence concerns the gene ACE and Myocardial fibrosis.